Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Manjer

Showing results (111-120 of 309) with videos related to

Pageof 31
Sort By:
International Journal of Cancer|March 1, 2019
Linear age-course effects on the associations between body mass index, triglycerides, and female breast and male liver cancer risk: An internal replication study of 800,000 individualsChristel Häggström, Håkan Jonsson, Tone Bjørge, et al.
Wiener Klinische Wochenschrift|November 19, 2009
Long-term temporal trends in cardiovascular and metabolic risk factorsWegene Borena, Tanja Stocks, Susanne Strohmaier, et al.
BMJ (Clinical Research Ed.)|September 17, 2010
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control studyAndrew J Vickers, Angel M Cronin, Thomas Björk, et al.
JAMA|October 11, 2012
Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortalityOlle Melander, Alan S Maisel, Peter Almgren, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 14, 2014
Validation of plasma proneurotensin as a novel biomarker for the prediction of incident breast cancerOlle Melander, Mattias Belting, Jonas Manjer, et al.
Oncotarget|March 10, 2016
Germline genetics of cancer of unknown primary (CUP) and its specific subtypesKari Hemminki, Bowang Chen, Abhishek Kumar, et al.
Journal of the National Cancer Institute|January 17, 2023
Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled studyMing Sun, Josef Fritz, Christel Häggström, et al.
Redox Biology|September 26, 2021
Serum selenium, selenoprotein P and glutathione peroxidase 3 as predictors of mortality and recurrence following breast cancer diagnosis: A multicentre cohort studyKamil Demircan, Ylva Bengtsson, Qian Sun, et al.
Plos Medicine|December 23, 2009
Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohortsTanja Stocks, Kilian Rapp, Tone Bjørge, et al.
American Journal of Epidemiology|December 22, 2016
Inflammatory Cytokines and Lung Cancer Risk in 3 Prospective StudiesDarren R Brenner, Anouar Fanidi, Kjell Grankvist, et al.
Pageof 31

Showing results (111-120 of 309) with videos related to

Sort By:
Pageof 31
International Journal of Cancer|March 1, 2019
Linear age-course effects on the associations between body mass index, triglycerides, and female breast and male liver cancer risk: An internal replication study of 800,000 individualsChristel Häggström, Håkan Jonsson, Tone Bjørge, et al.
Wiener Klinische Wochenschrift|November 19, 2009
Long-term temporal trends in cardiovascular and metabolic risk factorsWegene Borena, Tanja Stocks, Susanne Strohmaier, et al.
BMJ (Clinical Research Ed.)|September 17, 2010
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control studyAndrew J Vickers, Angel M Cronin, Thomas Björk, et al.
JAMA|October 11, 2012
Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortalityOlle Melander, Alan S Maisel, Peter Almgren, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 14, 2014
Validation of plasma proneurotensin as a novel biomarker for the prediction of incident breast cancerOlle Melander, Mattias Belting, Jonas Manjer, et al.
Oncotarget|March 10, 2016
Germline genetics of cancer of unknown primary (CUP) and its specific subtypesKari Hemminki, Bowang Chen, Abhishek Kumar, et al.
Journal of the National Cancer Institute|January 17, 2023
Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled studyMing Sun, Josef Fritz, Christel Häggström, et al.
Redox Biology|September 26, 2021
Serum selenium, selenoprotein P and glutathione peroxidase 3 as predictors of mortality and recurrence following breast cancer diagnosis: A multicentre cohort studyKamil Demircan, Ylva Bengtsson, Qian Sun, et al.
Plos Medicine|December 23, 2009
Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohortsTanja Stocks, Kilian Rapp, Tone Bjørge, et al.
American Journal of Epidemiology|December 22, 2016
Inflammatory Cytokines and Lung Cancer Risk in 3 Prospective StudiesDarren R Brenner, Anouar Fanidi, Kjell Grankvist, et al.
Pageof 31